Share Prices & Company Research

Stockbroking

Oxford Biomedica Plc

Current Price 1448.00p Bid 1440.00p Ask 1484.00p Change -6.46%
Last Updated: 19/09/2021 14:56. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Financial Highlights Year Ended 31/12/2020

Revenue
£87.73m
Operating Profit/Loss
£-5.69m
Dividend yield (%)
n/a
Total dividend for year
n/ap
Dividend cover
n/a
P/E Ratio
n/a

Key Personnel

Mr John Dawson
Chief Executive Officer
Mr Stuart Paynter
Chief Financial Officer
Mr Stuart Henderson
Deputy Chairman
Dr Heather Preston
Independent Non-Executive Director
Dr Roch Doliveux
Non-Executive Chairman
Dr Michael Hayden
Non-Executive Director
Dr Siyamak Rasty
Non-Executive Director
Mr Dame Kay Davies
Non-Executive Director
Mr Robert Ghenchev
Non-Executive Director

Stock Details

EPIC
OXBL
ISIN
GB0006648157
Shares in Issue
0.00m
Market cap
£0.00m

Price Summary

Mid Price
1,448.00p
Bid Price
1,440.00p
Ask Price
1,484.00p
Volume
18,529
Change Today
-100.00p
% Change Today
-6.46%
Open
1,526.00p
Previous Close
1,448.00p
Intraday High
1,542.00p
Intraday Low
1,444.00p
52 Week High
1,548.00p
52 Week Low
780.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

News

Income Statement

Year End Date
31 Dec 2020
31 Dec 2019
 
£ (M)
£ (M)
Continuing Operations
Revenue
87.73
64.06
Operating Profit/Loss
-5.69
-14.47
Net Interest
-0.88
-6.42
Pre-Tax Profit
-6.57
-20.89
Profit After Tax from continuing operations
-6.25
-16.07
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
-6.25
-16.07
Attributable to:
Equity Holders of Parent Company
-6.25
-16.07
Minority Interests
n/a
n/a
Total Dividend Paid
n/ap
n/ap
Retained Profit/(Loss) for the Financial Year
n/a
n/a

Earnings per Share

Year End Date
31 Dec 2020
31 Dec 2019
Basic
-7.81p
-22.10p
Diluted
-7.81p
-22.10p
Adjusted
-7.81p
-22.10p
Dividend per Share
n/ap
n/ap

Assets

Year End Date
31 Dec 2020
31 Dec 2019
 
£ (M)
£ (M)
Non-Current Assets
Property, Plant & Equipment
72.30
61.93
Intangible Assets
0.07
0.10
Investment Properties
n/a
n/a
Investments
n/a
n/a
Other Financial Assets
n/a
n/a
Other Non-Current Assets
3.61
3.96
Current Assets
Inventories
6.91
2.58
Trade & Other Receivables
53.93
30.05
Cash at Bank & In Hand
46.74
16.24
Current Asset Investments
n/a
n/a
Other Current Assets
0.37
8.07
Other Assets
n/a
n/a
Total Assets
183.93
122.93

Liabilities

Year End Date
31 Dec 2020
31 Dec 2019
 
£ (M)
£ (M)
Current Liabilities
Borrowings
4.47
0.48
Other Current Liabilities
47.98
28.46
Total Current Liabilities
52.45
28.94
Non-Current Liabilities
Borrowings
9.37
7.91
Provisions
5.84
5.45
Other Non-Current Liabilities
3.52
5.00
Total Non-Current Liabilities
18.73
18.36
Other Liabilities
n/a
n/a
Total Liabilities
71.18
47.30

Net Assets

Year End Date
31 Dec 2020
31 Dec 2019
 
£ (M)
£ (M)
Net Assets
112.75
75.63

Capital & Reserves

Year End Date
31 Dec 2020
31 Dec 2019
 
£ (M)
£ (M)
Share Capital
41.16
38.42
Share Premium Account
258.02
222.62
Other Reserves
2.29
2.29
Retained Earnings
-188.72
-187.70
Shareholders Funds
112.75
75.63
Minority Interests/Other Equity
n/a
n/a
Total Equity
112.75
75.63

Dividend History

Dividend Metrics

Year End Date
31 Dec 2020
31 Dec 2019
Dividend growth
n/a%
n/a%
Dividend yield
n/a%
n/a%
Dividend cover
n/a
n/a


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.